FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

108422002: Dolasetron mesilate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
172956017 Dolasetron mesylate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2694786010 Dolasetron mesilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726181015 Dolasetron mesilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3191451000005111 dolasetronmesylat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dolasetron mesilate Is a Product containing dolasetron (medicinal product) false Inferred relationship Some
Dolasetron mesilate Is a Dolasetron (substance) false Inferred relationship Some
Dolasetron mesilate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. 5-HT3 receptor antagonist true Inferred relationship Some
Dolasetron mesilate Is a 5-HT3 receptor antagonist true Inferred relationship Some
Dolasetron mesilate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Dolasetron (substance) true Inferred relationship Some
Dolasetron mesilate Is a Drug allergen false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
dolasetronmesilat 20 mg/ml injektionsvæske, opløsning, hætteglas a 0,625 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesilate Inferred relationship Some
dolasetronmesilat 20 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesilate Inferred relationship Some
Dolasetron mesilate 20 mg powder for solution for injection ampoule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesilate Inferred relationship Some
Dolasetron mesilate 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesilate Inferred relationship Some
Dolasetron mesilate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesilate Inferred relationship Some
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesilate Inferred relationship Some
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesilate Inferred relationship Some 1
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dolasetron mesilate Inferred relationship Some 1
Dolasetron mesilate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesilate Inferred relationship Some 1
Dolasetron mesilate 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dolasetron mesilate Inferred relationship Some 1
Dolasetron mesilate 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dolasetron mesilate Inferred relationship Some 1
Dolasetron mesilate 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dolasetron mesilate Inferred relationship Some 1
Dolasetron mesilate 200 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dolasetron mesilate Inferred relationship Some 1
Product containing precisely dolasetron mesilate 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dolasetron mesilate Inferred relationship Some 1
Dolasetron mesilate 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dolasetron mesilate Inferred relationship Some 1
Dolasetron mesilate 20 mg powder for solution for injection ampoule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Dolasetron mesilate Inferred relationship Some 1
Dolasetron mesilate 20 mg powder for solution for injection ampoule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Dolasetron mesilate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start